Skip survey header

9099 Reversing DOACs: Providing Answers on Why, When, How

Reversing DOACs: Providing Answers on Why, When, and How? International Society on Thrombosis and Haemostasis

DEMOGRAPHICS
6. Do you intend to make changes or apply new knowledge to your practice as a result of this activity? *This question is required.
If you answered yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity. *This question is required.
7. Please rate your ability to apply the following in your practice BEFORE the activity *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
Discuss with clinical colleagues the appropriate use of specific DOAC reversal agents
Explain efficacy and safety of the pharmacotherapeutic options for DOAC reversal
Advise on appropriate institutional approaches to DOAC reversal agents
8. Please rate your ability to apply the following in your practice AFTER the activity *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
Discuss with clinical colleagues the appropriate use of specific DOAC reversal agents
Explain efficacy and safety of the pharmacotherapeutic options for DOAC reversal
Advise on appropriate institutional approaches to DOAC reversal agents
14. In the event of a severe or life-threatening bleed in a patient treated with a DOAC, the anticoagulant effect of the DOAC cannot be reversed. *This question is required.
15. Which of the following is true in the event of severe or life-threatening bleeding in a patient being treated with a DOAC? *This question is required.
16. For patients with DOAC-related bleeding, which of the following is the first and most important management step? *This question is required.